🔎 Trials Near Me

Home › Soft Tissue Sarcoma › California › Mountain View

Soft Tissue Sarcoma clinical trials in Mountain View, CA

6 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

RecruitingPhase 1/2
  • Stanford University, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

5-Day Preoperative Radiation for Soft Tissue Sarcoma

RecruitingPhase 2
  • Stanford University, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06087861

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
  • Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi away
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 2 to 30 · All sexes · Updated May 7, 2026 · NCT06500819

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

RecruitingPhase 1/2
  • Lucile Packard Children's Hospital, Palo Alto · 5 mi away
Ages 2 to 30 · All sexes · Updated Feb 3, 2026 · NCT05734066

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

RecruitingPhase 1/2
  • Stanford Hospital & Clinics, Stanford · 5 mi away
Ages 15 and older · All sexes · Updated Aug 12, 2025 · NCT06298916

About Soft Tissue Sarcoma

Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available

More about Soft Tissue Sarcoma on MedlinePlus

Soft Tissue Sarcoma trials in other cities

Other studies in Mountain View

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.